Log in

3737 Zhongzhi Pharmaceutical Holdings Limited HKEX · China

Zhongzhi Pharmaceutical Holdings (3737) news

Zhongzhi Pharmaceutical Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 3737, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Zhongzhi Pharmaceutical Holdings news

We have not published a story on Zhongzhi Pharmaceutical Holdings yet. When there is news, it will appear here.

Questions about Zhongzhi Pharmaceutical Holdings

What is the ticker symbol of Zhongzhi Pharmaceutical Holdings?

Zhongzhi Pharmaceutical Holdings Limited trades under the ticker 3737 on HKEX.

Where is Zhongzhi Pharmaceutical Holdings listed?

Zhongzhi Pharmaceutical Holdings Limited is listed on HKEX.

Which country or territory is Zhongzhi Pharmaceutical Holdings listed under?

Our directory records Zhongzhi Pharmaceutical Holdings Limited under China.

What does Zhongzhi Pharmaceutical Holdings do?

Our directory classifies Zhongzhi Pharmaceutical Holdings Limited as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Zhongzhi Pharmaceutical Holdings?

The ISIN recorded for Zhongzhi Pharmaceutical Holdings Limited is KYG989611085.

Does aibio.space cover Zhongzhi Pharmaceutical Holdings?

aibio.space lists Zhongzhi Pharmaceutical Holdings Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Zhongzhi Pharmaceutical Holdings?

Companies in our directory listed in the same country and business area as Zhongzhi Pharmaceutical Holdings: Guangdong Jiaying Pharmaceutical Co., GuangYuYuan Chinese Herbal Medicine Co., Zhejiang Medicine Co., Sihuan Pharmaceutical Holdings Group, NOVAST LABORATORIES LTD, Lanzhou Foci Pharmaceutical Co..

Investor discussion: Zhongzhi Pharmaceutical Holdings

Members talk about Zhongzhi Pharmaceutical Holdings (3737). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Zhongzhi Pharmaceutical Holdings, newest first. Each line links the filing it comes from.

  1. Financings

    Share or debt issue: (1) GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES (2) RE-ELECTION OF DIRECTORS (3) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source

  2. Financings

    Share or debt issue: (1) GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES (2) PROPOSED PAYMENT OF FINAL DIVIDEND OUT OF SHARE PREMIUM ACCOUNT (3) RE-ELECTION OF DIRECTORS AND (4) NOTICE OF ANNUAL GENERAL MEETING. Source

Press releases

Headlines of Zhongzhi Pharmaceutical Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    Notification Letter to Non-Registered Shareholders

  2. HKEXnews

    Notification Letter and Reply Form to Registered Shareholders

  3. HKEXnews

    INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026

  4. HKEXnews

    AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  5. HKEXnews

    POLL RESULTS OF 2026 ANNUAL GENERAL MEETING

  6. HKEXnews

    NOTICE OF ANNUAL GENERAL MEETING

  7. HKEXnews

    (1) GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES (2) RE-ELECTION OF DIRECTORS (3) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND (4) NOTICE OF ANNUAL GENERAL MEETING

  8. HKEXnews

    ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025

  9. HKEXnews

    PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION

  10. HKEXnews

    PROFIT WARNING

  11. HKEXnews

    INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025

  12. HKEXnews

    POLL RESULTS OF 2025 ANNUAL GENERAL MEETING

  13. HKEXnews

    TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE

  14. HKEXnews

    (1) GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES (2) PROPOSED PAYMENT OF FINAL DIVIDEND OUT OF SHARE PREMIUM ACCOUNT (3) RE-ELECTION OF DIRECTORS AND (4) NOTICE OF ANNUAL GENERAL MEETING

  15. HKEXnews

    CHANGE OF DIRECTORS

  16. HKEXnews

    Final Dividend for the Year Ended 31 December 2024

  17. HKEXnews

    ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024

  18. HKEXnews

    VOLUNTARY ANNOUNCEMENT

  19. HKEXnews

    VOLUNTARY ANNOUNCEMENT IN RELATION TO CONTRACTUAL ARRANGEMENT

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:3737 on TradingView.

Listing details

Zhongzhi Pharmaceutical Holdings Limited is a public biotech or pharmaceutical company listed on HKEX under the ticker 3737, recorded under China. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Zhongzhi Pharmaceutical Holdings Limited
Ticker
3737
Listing
HKEX
Country or territory
China
Business scope
Biopharma / pharmaceutical profile checked
ISIN
KYG989611085
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.